This analysis reframes investor protection by enhancing observability in complex financial systems, suggesting new frameworks for supervision.
Investor protection has traditionally been grounded in legal classification and ex-ante authorization. Financial instruments are categorized, market actors are licensed, and disclosure obligations are imposed within predefined regulatory taxonomies. While this architecture has historically enhanced legal certainty and mitigated information asymmetries, its effectiveness presupposes relative ontological stability of the regulated objects. Contemporary financial markets, however, operate as complex adaptive systems characterized by structural hybridity, endogenous innovation, and radical uncertainty. In such environments, risk accumulates within dynamic economic flows rather than static legal forms. Classification compresses economic complexity into discrete categories, stabilizing language but not necessarily underlying processes. This paper reconceptualizes investor protection as a problem of system observability under radical uncertainty. Drawing on information economics, complexity theory, and control systems theory, it argues that effective supervision cannot rely exclusively on categorical authorization. Instead, investor protection must be architected through structured observability, verifiability, and adaptive responsiveness. The paper introduces the Investor Protection Stack, a multilayered framework that integrates economic substance mapping, continuous observability mechanisms, verification infrastructures, and dynamic safeguards. Within this architecture, protection emerges not as a binary regulatory status but as a systemic property of informational design. By reframing supervision as an adaptive component of complex financial systems, the analysis moves beyond the dichotomy of “more” versus “less” regulation. The central challenge is not regulatory density, but epistemic coherence between supervisory architecture and systemic complexity.
No takes yet. Share an insight, caveat, or question.
Andrea Cesaretti (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: